ImmunoGen
IMGN
#2139
Rank
ยฃ6.51 B
Marketcap
ยฃ23.33
Share price
0.00%
Change (1 day)
118.59%
Change (1 year)

Market capitalization of ImmunoGen (IMGN)

Last known market cap: ยฃ6.51 Billion

On April 12, 2024 ImmunoGen had a market cap of ยฃ6.51 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of ImmunoGen from 2001 to 2024

End of year Market Cap

Year Marketcap Change
2024ยฃ6.95 B11.6%
2023ยฃ6.22 B588.29%
2022ยฃ0.90 B-25.2%
2021ยฃ1.20 B31.32%
2020ยฃ0.92 B57.64%
2019ยฃ0.58 B3.46%
2018ยฃ0.56 B-9.93%
2017ยฃ0.62 B334.58%
2016ยฃ0.14 B-81.89%
2015ยฃ0.79 B136.32%
2014ยฃ0.33 B-55.71%
2013ยฃ0.76 B14.67%
2012ยฃ0.66 B16.62%
2011ยฃ0.56 B39.56%
2010ยฃ0.40 B46.59%
2009ยฃ0.27 B87.23%
2008ยฃ0.14 B65.89%
2007ยฃ89.61 M-16.85%
2006ยฃ0.10 B-11.81%
2005ยฃ0.12 B-34.99%
2004ยฃ0.18 B64.05%
2003ยฃ0.11 B40.45%
2002ยฃ81.59 M-82.06%
2001ยฃ0.45 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Seagen
SGEN
ยฃ32.24 B 394.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ131.70 B 1,920.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ717.57 B 10,909.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ82.41 B 1,164.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ371.45 B 5,599.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ106.99 B 1,541.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ195.04 B 2,892.48%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
ยฃ87.85 B 1,248.01%๐Ÿ‡ซ๐Ÿ‡ท France